Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Olaf Diehl"'
Autor:
Tamara Göbel, Olaf Diehl, Jan Heering, Daniel Merk, Carlo Angioni, Sandra K. Wittmann, Estel.la Buscato, Ramona Kottke, Lilia Weizel, Tim Schader, Thorsten J. Maier, Gerd Geisslinger, Manfred Schubert-Zsilavecz, Dieter Steinhilber, Ewgenij Proschak, Astrid S. Kahnt
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Cysteinyl leukotriene receptor 1 antagonists (CysLT1RA) are frequently used as add-on medication for the treatment of asthma. Recently, these compounds have shown protective effects in cardiovascular diseases. This prompted us to investigate their in
Externí odkaz:
https://doaj.org/article/a80e026f90b747f8b7674c1f676db0f4
Autor:
Daniel Merk, René Blöcher, Olaf Diehl, Sandra K. Wittmann, Ewgenij Proschak, Manfred Schubert-Zsilavecz, Thomas Hanke, Astrid S. Kahnt, Christina Lamers, Dieter Steinhilber
Publikováno v:
MedChemComm. 7:1209-1216
Metabolic syndrome (MetS) is a widespread, complex disease cluster which consists of hypertension, atherosclerosis, dyslipidaemia and type II diabetes. The treatment of MetS requires multiple pharmaceutical agents leading to complex polypharmacy. Mul
Autor:
Mario Wurglics, Ewgenij Proschak, Evi Kostenis, Christina Lamers, Markus Hartmann, Sandra K. Wittmann, Carlo Angioni, Manfred Schubert-Zsilavecz, Jan Heering, Lilia Weizel, Olaf Diehl, Astrid S. Kahnt, Manuel Grundmann, Tamara Göbel, Astrid Brüggerhoff, René Blöcher, Gerd Geisslinger, Dieter Steinhilber, Daniel Merk, Astrid Kaiser, Bernhard Brüne, Marcel Boß, Tim Schader
Publikováno v:
Journal of Medicinal Chemistry. 59:61-81
Metabolic syndrome (MetS) is a multifactorial disease cluster that consists of dyslipidemia, cardiovascular disease, type 2 diabetes mellitus, and obesity. MetS patients are strongly exposed to polypharmacy; however, the number of pharmacological com
Autor:
Svenja Dorothea Steinbrink, Carlo Angioni, Sabine Grösch, Bettina Hofmann, Thorsten J. Maier, Christoph Lehmann, Gerd Geisslinger, Dieter Steinhilber, Olaf Diehl, Florian Rörsch, Astrid S. Kahnt
Publikováno v:
Kahnt, A S, Rörsch, F, Diehl, O, Hofmann, B, Lehmann, C, Steinbrink, S D, Angioni, C, Geisslinger, G, Grösch, S, Steinhilber, D & Maier, T 2013, ' Cysteinyl leukotriene-receptor-1 antagonists interfere with PGE2 synthesis by inhibiting mPGES-1 activity ', Biochemical Pharmacology, vol. 86, no. 2, pp. 286-96 . https://doi.org/10.1016/j.bcp.2013.05.005
Because of their favourable safety profile and beneficial anti-inflammatory properties, the CysLT1 receptor antagonists (LTRA), montelukast, zafirlukast and pranlukast are approved for the treatment of asthma and are frequently prescribed as add-on t
Publikováno v:
Pharmacologytherapeutics. 148
The association between vitamin D and multiple sclerosis has (re)-opened new interest in nutrition and natural compounds in the prevention and treatment of this neuroinflammatory disease. The dietary amount and type of fat, probiotics and biologicals
Publikováno v:
The Journal of the American Dental Association. 126:1145-1148
It is well known that the occurrence of bacteremia after dental procedures can place certain patients at risk for bacterial endocarditis. The authors compared the efficacy of two antiseptic agents in the prevention of post-treatment bacteremia in 120
Autor:
Göbel, Tamara, Diehl, Olaf, Heering, Jan, Merk, Daniel, Angioni, Carlo, Wittmann, Sandra K., Buscato, Estel.la, Kottke, Ramona, Weizel, Lilia, Schader, Tim, Maier, Thorsten J., Geisslinger, Gerd, Schubert-Zsilavecz, Manfred, Steinhilber, Dieter, Proschak, Ewgenij, Kahnt, Astrid S.
Publikováno v:
Frontiers in Pharmacology; 3/20/2019, pN.PAG-N.PAG, 15p
Publikováno v:
European Journal of Ageing; Dec2006, Vol. 3 Issue 4, p217-217, 1p
Publikováno v:
Pharmazie in userer Zeit; Mar2008, Vol. 37 Issue 2, p172-174, 3p
Autor:
PR Newswire
Publikováno v:
PR Newswire US. 03/02/2020.